Gut Dysbiosis After Antibiotics or Chronic Illness

What the standard model gets wrong

The standard model treats dysbiosis as a composition problem. The wrong bacteria are present, and the right bacteria are absent. The intervention is to remove the wrong ones (antimicrobials) and add the right ones (probiotics, prebiotics, sometimes FMT). The underlying assumption is that the community state is the disease.

The clinical results of this strategy are inconsistent. Some patients respond well. Many relapse. The relapse is attributed to insufficient duration of treatment, wrong strain selection, dietary non-compliance, or persistent overgrowth. These explanations do not survive contact with cases that have been through every variation and still relapse.

The framework is wrong. The community state is downstream of the habitat. Until the habitat changes, the same community keeps selecting itself. The microbial signature is the readout, not the lesion.

What the Host Capacity Model says about dysbiosis

A healthy colonic habitat is anaerobic at the mucosal surface. Colonocytes oxidize butyrate, which consumes oxygen and steepens the gradient. Strict anaerobes — Roseburia, Faecalibacterium, Eubacterium, and others — dominate. These are the butyrate producers. Their presence sustains the substrate that feeds the colonocyte that maintains the gradient that supports them. It is a stable loop.

Antibiotic exposure, chronic inflammation, post-viral mitochondrial damage, NAD+ depletion, or iron-sulfur cluster insufficiency disrupt this loop at the colonocyte level. The cell loses oxidative capacity. The gradient flattens. Strict anaerobes recede. Facultative organisms expand. The community shifts.

The shifted community has its own metabolites. Sulfur-reducing bacteria produce hydrogen sulfide. Proteolytic populations produce ammonia and biogenic amines. Methane producers change motility. Each of these changes the local environment further, reinforcing the dysbiotic state and making it harder for the resident producers to return even if their substrate is supplied.

The candidate mechanism is therefore a feedback failure at the host level, not a population invasion. The bacteria are doing what bacteria do — colonizing the habitat that is offered. Changing the habitat is what changes the bacteria.

Patterns I look for in cases like this

• Onset traceable to a specific antibiotic course or sequence of courses.
• Onset after a confirmed viral infection.
• Inconsistent response to probiotics that worked for friends or family.
• Symptoms that change quality but never fully resolve through repeated antimicrobial cycles.
• Worsening after high-fiber meals despite "good" food choices.
• A history of FMT or extensive probiotic experimentation with transient benefit.
• Concurrent histamine or mast cell features.
• Bloating, transit changes, and stool form drift that track with bioenergetic state.
• Low butyrate on functional stool testing despite adequate fiber intake.
• Elevated barrier markers (zonulin, LPS, calprotectin) suggesting habitat-level dysfunction.

Tests I usually want to see

• Shotgun metagenomics — full taxonomy and functional gene content.
• Stool short-chain fatty acid panel — butyrate level above all.
• Barrier markers — zonulin, LPS, LBP, calprotectin.
• Organic Acid Test — host bioenergetic flux markers and microbial metabolite markers.
• Intracellular NAD+ panel — colonocyte bioenergetic capacity context.
• SIBO breath test where small bowel topology is suspected.
• Bile acid panel where bile-acid-driven dysbiosis is in play.
• hs-CRP and immune activation panel — endotoxin-driven inflammation context.

Leverage points

Restoring colonocyte bioenergetic capacity is the foundation. NAD+ restoration, mitochondrial cofactor support, and protecting recovery from re-perturbation come before community-level intervention because the community will follow the habitat.

Substrate provision is the second leverage point. Supplemental butyrate during recovery while producers re-establish. Polyphenol density and varied plant fiber as tolerance rebuilds. Resistant starch in measured introduction. The goal is feeding the recovering community, not chasing the displaced one.

Antimicrobials are tools, not treatments. They are useful for managing symptom load and reducing dominant dysbiotic populations during the recovery window. Used cyclically without addressing the habitat, they prolong the cycle.

Probiotics have a role as transient signaling presence — many of their benefits come from metabolites produced during transit rather than from sustained colonization. Selection should be deliberate, dose meaningful, and expectations calibrated. Probiotics are not a cure for habitat failure.

Where this account may be wrong

Acute Clostridioides difficile infection is a different disease and requires its own management. Some primary motility disorders produce dysbiosis-like patterns that have a different upstream lesion. The habitat-failure model is offered for the chronic post-antibiotic and post-illness population that fails standard protocols — which is the largest subgroup of refractory dysbiosis in current practice.

Frequently asked questions

Related reading

• The Host Capacity Model
• Dysbiosis ecology
• Dysbiosis treatment framework
• Colonocyte bioenergetics
• Oxygen gradient failure